Avid Bioservices Inc (CDMO)

[entdoc]

The one over-riding consideration here is what does the company and any sub rosa sponsor (as before) now know about Bavituximab effects on cancer that we don't know. All this legal/financial buzz is interesting, but I would be willing to bet as much as I lost last week that someone knows one heck of a lot more about Bavi NOW about months of survival with or without. Virtually every possible error can be mathematically modeled and odds calculated. Bavi and no Doce. Doce +Bavi, yada. I'll say it again. Do the math. This is not rocket science. We are back to exactly where we were a few weeks ago with the stock price-wise, and NOT where we should be with the knowledge which has been accrued. Does a simple answer to these questions seem possible at this point? "It looks like Bavi works. It doesn't look like Bavi works. We still have no clue whether Bavi works." Let's stay focused. Somebody DOES know, and that somebody was buying big.